Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Quasiexperimental intervention study protocol to optimise the use of new antibiotics in Spain: the NEW_SAFE project.
Palacios-Baena ZR, Valiente de Santis L, Maldonado N, Rosso-Fernández CM, Borreguero I, Herrero-Rodríguez C, López-Cárdenas S, Martínez-Marcos FJ, Martín-Aspas A, Jiménez-Aguilar P, Castón JJ, Anguita-Santos F, Ojeda-Burgos G, Aznarte-Padial MP, Praena-Segovia J, Corzo-Delgado JE, Esteban-Moreno MÁ, Rodríguez-Baño J, Retamar P. Palacios-Baena ZR, et al. Among authors: retamar p. BMJ Open. 2020 Jul 31;10(7):e035460. doi: 10.1136/bmjopen-2019-035460. BMJ Open. 2020. PMID: 32737088 Free PMC article.
Opportunities for antibiotic optimisation and outcome improvement in patients with negative blood cultures: study protocol for a cluster-randomised crossover trial, the NO-BACT study.
Jiménez-Jorge S, Palacios-Baena ZR, Rosso-Fernández CM, Girón-Ortega JA, Rodriguez-Baño J, Retamar P. Jiménez-Jorge S, et al. Among authors: retamar p. BMJ Open. 2019 Dec 18;9(12):e030062. doi: 10.1136/bmjopen-2019-030062. BMJ Open. 2019. PMID: 31857298 Free PMC article.
Temocillin versus meropenem for the targeted treatment of bacteraemia due to third-generation cephalosporin-resistant Enterobacterales (ASTARTÉ): protocol for a randomised, pragmatic trial.
Marín-Candón A, Rosso-Fernández CM, Bustos de Godoy N, López-Cerero L, Gutiérrez-Gutiérrez B, López-Cortés LE, Barrera Pulido L, Borreguero Borreguero I, León MJ, Merino V, Camean-Fernández M, Retamar P, Salamanca E, Pascual A, Rodriguez-Baño J; ASTARTÉ Study Group. Marín-Candón A, et al. Among authors: retamar p. BMJ Open. 2021 Sep 27;11(9):e049481. doi: 10.1136/bmjopen-2021-049481. BMJ Open. 2021. PMID: 34580096 Free PMC article.
Targeted simplification versus antipseudomonal broad-spectrum beta-lactams in patients with bloodstream infections due to Enterobacteriaceae (SIMPLIFY): a study protocol for a multicentre, open-label, phase III randomised, controlled, non-inferiority clinical trial.
López-Cortés LE, Rosso-Fernández C, Núñez-Núñez M, Lavín-Alconero L, Bravo-Ferrer J, Barriga Á, Delgado M, Lupión C, Retamar P, Rodríguez-Baño J; SIMPLIFY Study Group. López-Cortés LE, et al. Among authors: retamar p. BMJ Open. 2017 Jun 9;7(6):e015439. doi: 10.1136/bmjopen-2016-015439. BMJ Open. 2017. PMID: 28601833 Free PMC article. Clinical Trial.
Seven-versus 14-day course of antibiotics for the treatment of bloodstream infections by Enterobacterales: a randomized, controlled trial.
Molina J, Montero-Mateos E, Praena-Segovia J, León-Jiménez E, Natera C, López-Cortés LE, Valiente L, Rosso-Fernández CM, Herrero M, Aller-García AI, Cano Á, Gutiérrez-Gutiérrez B, Márquez-Gómez I, Álvarez-Marín R, Infante C, Roca C, Valiente-Méndez A, Pachón J, Reguera JM, Corzo-Delgado JE, Torre-Cisneros J, Rodríguez-Baño J, Cisneros JM; SHORTEN trial team. Molina J, et al. Clin Microbiol Infect. 2022 Apr;28(4):550-557. doi: 10.1016/j.cmi.2021.09.001. Epub 2021 Sep 9. Clin Microbiol Infect. 2022. PMID: 34508886 Free article. Clinical Trial.
Current management of bloodstream infections.
Rodríguez-Baño J, de Cueto M, Retamar P, Gálvez-Acebal J. Rodríguez-Baño J, et al. Among authors: retamar p. Expert Rev Anti Infect Ther. 2010 Jul;8(7):815-29. doi: 10.1586/eri.10.49. Expert Rev Anti Infect Ther. 2010. PMID: 20586566 Review.
β-Lactam/β-lactam inhibitor combinations for the treatment of bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli: a post hoc analysis of prospective cohorts.
Rodríguez-Baño J, Navarro MD, Retamar P, Picón E, Pascual Á; Extended-Spectrum Beta-Lactamases–Red Española de Investigación en Patología Infecciosa/Grupo de Estudio de Infección Hospitalaria Group. Rodríguez-Baño J, et al. Among authors: retamar p. Clin Infect Dis. 2012 Jan 15;54(2):167-74. doi: 10.1093/cid/cir790. Epub 2011 Nov 4. Clin Infect Dis. 2012. PMID: 22057701
Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study.
Gutiérrez-Gutiérrez B, Del Toro MD, Borobia AM, Carcas A, Jarrín I, Yllescas M, Ryan P, Pachón J, Carratalà J, Berenguer J, Arribas JR, Rodríguez-Baño J; REIPI-SEIMC COVID-19 group and COVID@HULP groups. Gutiérrez-Gutiérrez B, et al. Lancet Infect Dis. 2021 Jun;21(6):783-792. doi: 10.1016/S1473-3099(21)00019-0. Epub 2021 Feb 23. Lancet Infect Dis. 2021. PMID: 33636145 Free PMC article.
41 results